Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 3 December 2025

Sun Pharma Advanced Research (SPARC) Stock Soars After US Court Ruling on Sezaby PRV – What the 30% Two‑Day Rally on 3 December 2025 Really Means

Sun Pharma Advanced Research (SPARC) Stock Soars After US Court Ruling on Sezaby PRV – What the 30% Two‑Day Rally on 3 December 2025 Really Means

SPARC stock on 3 December 2025: Still volatile after a 2‑day surge Sun Pharma Advanced Research Company Ltd (SPARC) has exploded back onto traders’ screens this week. On 2 December 2025, the stock hit the 20% upper circuit at around ₹161.10, after a US court delivered a favourable ruling in a long‑running dispute over a Priority Review Voucher (PRV) linked to its neonatal seizure drug, Sezaby. Intra‑day data show around 27.7 million shares changing hands on the BSE, representing roughly 8.5% of the company’s equity, far above normal volumes. Business Standard+1 On 3 December 2025 (mid‑session), the rally extended: Despite
3 December 2025
·
SBI Share Price Today (3 December 2025): PSU Bank Sell-Off Tests State Bank of India Rally as Analysts Still See Upside

SBI Share Price Today (3 December 2025): PSU Bank Sell-Off Tests State Bank of India Rally as Analysts Still See Upside

State Bank of India (SBI) shares slipped in Wednesday’s session as public-sector banks came under pressure after the government clarified it is not considering a hike in foreign direct investment (FDI) limits in PSBs. Yet the stock remains close to its 52‑week high, is up strongly in 2025, and most brokerages continue to project further upside over the next 12 months. Fortune India+1 SBI share price today: key levels on 3 December 2025 By around midday (12:10–12:30 pm IST) on 3 December 2025, SBI was trading in the ₹952–₹955 range on the NSE, down roughly 1.4–1.6% versus the previous close
3 December 2025
·
Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys Limited (NSE: INFY, BSE: 500209, NYSE: INFY) spent December 3 trading firm against a weak broader market, with investors digesting fresh currency moves, a just-closed ₹18,000‑crore share buyback, and new tax headlines alongside steady Q2 FY26 earnings and a deepening AI pipeline. Infosys share price today: INFY holds firm as IT bucks the sell‑off Based on provisional end‑of‑day data, Infosys shares on the NSE closed around ₹1,583 per share on December 3, up roughly 1.4% versus the previous close of ₹1,561, with volume of about 6.7 million shares. Investing.com That move came on a day when India’s benchmark indices
3 December 2025
HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank Limited (NSE: HDFCBANK, BSE: 500180, NYSE: HDB) is trading almost flat on 3 December 2025, with investors weighing strong quarterly earnings against fresh regulatory headlines and higher capital requirements from the Reserve Bank of India (RBI).The Economic Times+1 Note: There is no separate “IHDFC Bank Limited” on the market — the listed entity is HDFC Bank Limited. 1. HDFC Bank share price today: where the stock stands India listing (NSE / BSE) Around midday on 3 December 2025, HDFC Bank shares are hovering close to ₹990–₹991, essentially flat after Monday’s profit‑taking.The Economic Times+1 Key near‑term stats from Indian
3 December 2025
Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea Ltd (NSE: IDEA, BSE: 532822) extended its sharp rally on 3 December 2025, with the stock trading around ₹10.5, up roughly 3.5–4% intraday, even as the broader Indian market stayed under pressure. The move comes amid heavy volumes, fresh speculation on government relief for adjusted gross revenue (AGR) dues, and a mixed but noisy chorus of broker forecasts. mint+2Markets Mojo+2 Below is a detailed roundup of everything that matters today for Vodafone Idea’s share price, including the latest news, key numbers from recent results, and how analysts are valuing the stock. Vodafone Idea share price today: rally extends
3 December 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 03.12.2025

ENDEDLive coverage has endedEnded: December 4, 2025, 12:00 AM EST Amanat Holdings PJSC Among Noteworthy Middle East Penny Stocks Amid Rally December 3, 2025, 11:45 PM EST. Amanat Holdings PJSC stands out in the Middle East penny stocks spotlight as a diversified education and healthcare investor with a market cap of AED2.86B. Revenue leans on Education (AED495.94M) and Healthcare (AED380.40M). The stock shows striking earnings growth of 330.2% year over year, helped by a one-off gain of AED68.3M, lifting net profit margin to 24.1% from 6.8%. The balance sheet remains solid, with assets covering liabilities and cash exceeding debt, and
3 December 2025
·
Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

As of the close on Tuesday, December 2, 2025, Cintas Corporation (NASDAQ: CTAS) – the uniform rental and facility‑services giant – is trading like a high‑quality franchise that investors suddenly fell out of love with. The share price sits around $184 per share, giving Cintas a market value in the mid‑$70 billion range and leaving the stock down roughly 16–17% over the last 12 months, even though the business continues to post high‑single‑digit revenue growth and expanding margins. StockAnalysis+1 Yet while the stock has cooled, new filings show large asset managers using the weakness to accumulate shares, and Wall Street
3 December 2025
·
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Company (NYSE: MMM) has quietly turned into one of 2025’s comeback stories on Wall Street. After years of legal headaches and sluggish growth, the industrial conglomerate now sits near a four‑year high, closing at $171.56 on 2 December 2025, just shy of its 52‑week peak around $172.85. That price gives 3M a market capitalization of about $91 billion, a trailing P/E of 27.4 and a forward P/E near 20.3, with a dividend yield around 1.7% on an annual payout of $2.92 per share. StockAnalysis Yet beneath the smooth headline numbers, investor views on 3M are sharply divided. Some see
3 December 2025
···
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

On December 2, 2025, Bristol-Myers Squibb (NYSE: BMY) found itself at the center of two very different storylines: a revived $6.7 billion Celgene lawsuit and strong hematology data at ASH 2025. Together with a hefty dividend and low valuation multiples, these cross-currents are shaping how investors see BMY stock heading into 2026. BMY Stock Snapshot on 2 December 2025 On a day when the S&P 500 rose 0.25% and the Dow gained 0.39%, BMY underperformed peers: Johnson & Johnson ticked up slightly, while Pfizer and Abbott fell less than Bristol-Myers. MarketWatch For investors watching Google News and Discover, the headline
3 December 2025
··
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management, Inc. (New) (NYSE: APO) entered December with a busy news day and a clear growth narrative that is catching Wall Street’s attention. On December 2, 2025, Apollo’s stock closed at $132.08, up 0.53% on the session, with after-hours trading nudging the price to $132.80. StockAnalysis Behind that modest price move sits a dense cluster of headlines: a fresh Goldman Sachs conference appearance, a Bank of England private-credit stress test, a Morgan Stanley upgrade and 20%+ growth forecasts, a high‑profile movie-studio auction where Apollo is helping finance a mega‑bid, and new macro commentary from Apollo’s own chief economist.
3 December 2025
·
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

As of December 2, 2025, CVS Health Corporation (NYSE: CVS) finds itself in a classic “good news, bad headlines” moment: the stock has pulled back after a strong 2025 rally, the company agreed to a federal settlement over insulin-pen billing, and yet Wall Street’s forecasts still point to further upside. Below is a structured rundown of the latest price action, news, forecasts and analyses as of and since December 2, 2025. Share price on December 2, 2025: dip after a big year On Tuesday, December 2, 2025, CVS Health shares fell about 1.9%, closing at $77.62, even as the broader
3 December 2025
···
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, has packed a lot of news into the turn of the month. On December 2, 2025, the company reported near-record trading volumes, secured U.S. regulatory approval for a new securities clearing house, and continued to deal with the reputational fallout from last week’s rare 10‑hour trading outage. At the same time, options traders and Wall Street analysts are re‑positioning around the stock. This article brings together all the major CME stock news, forecasts and analyses dated December 2, 2025 (and closely related developments) to give you a single, SEO‑friendly
3 December 2025
ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (NYSE: COP) heads into the final month of 2025 as one of the most hotly debated energy stocks on Wall Street. On Tuesday, December 2, 2025, COP closed at $89.29, down 1.07% on the day, even as the S&P 500 and Dow Jones notched modest gains. That leaves the stock about 17% below its 52‑week high of $107.67, reached on December 3 last year, and still in the lower half of its trading range between $79.88 and $108.74. MarketWatch+1 Yet analysts broadly agree the stock may be trading at a discount: consensus 12‑month price targets cluster around $113–$116, implying
3 December 2025
··
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare, Inc. (NYSE:HCA) is ending 2025 on a powerful note. After a year of double‑digit earnings growth and upgraded guidance, HCA stock is trading just above $500 per share, close to its 52‑week high of $520 and implying a market capitalization around $117 billion. MarketBeat On November 25, the stock touched an all‑time high of $515.85, and as of December 2 it was still near $503, more than 38% above its July 2024 peak of $363.05 — a rally powered by strong results from the company’s 191‑hospital network and an aggressive capital program. Becker’s Hospital Review This article rounds
3 December 2025
·
Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

TORONTO / NEW YORK — As of the close on 2 December 2025, Brookfield Corporation (NYSE: BN, TSX: BN) remains one of the most closely watched global alternative asset managers, sitting at the intersection of infrastructure, energy transition, AI data centers and retirement savings. On Tuesday, Brookfield’s own investor site showed BN at about US$46.46 on the NYSE (up 0.17% on the day) and C$65.01 on the TSX (up 0.22%), leaving the group valued at well over US$100 billion in market capitalization. Brookfield Corporation+1 Below is a detailed look at what changed around December 2, 2025, including institutional buying, balance-sheet
3 December 2025
···
Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Key takeaways This article is for information and education only and is not financial advice or a recommendation to buy or sell any security. 1. How Booking Holdings stock has traded since December 2, 2025 As of the close on December 2, 2025, Booking Holdings finished the session at about $5,135.07, up 4.97% from the prior close of $4,891.81. Intraday, the stock traded between roughly $4,903 and $5,176, on heavier‑than‑usual volume. Google+1 That rally leaves BKNG: A December 2 note from StockInvest upgraded BKNG to a “Buy candidate” after the strong session, citing: StockInvest However, the same model remains cautious
3 December 2025
···
TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

The TJX Companies, Inc. (NYSE:TJX) – owner of TJ Maxx, Marshalls, HomeGoods, TK Maxx and other off‑price banners – is heading into the crucial holiday period trading just below record highs after a strong third quarter and a flurry of fresh analyst and fund‑flow updates. As of the close on December 2, 2025, TJX shares changed hands around $150, within a whisker of their 52‑week high of $154.66 and well above the 52‑week low of $112.10. The market values the company at roughly $167 billion, with the stock on about 33x trailing earnings, according to Benzinga and StockInvest data. Benzinga
3 December 2025
··
BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock, Inc. (NYSE: BLK), the world’s largest asset manager, entered December 2025 at the center of several powerful themes: the AI infrastructure build‑out, a booming Bitcoin ETF franchise, shifting views on long‑term Treasuries, and intensifying ESG politics. On 2 December 2025, BLK shares closed at about $1,038.62, down a modest 0.13% on the day and roughly flat for the year, even as Wall Street price targets still point to double‑digit upside. Investing.com+1 Below is a detailed rundown of the latest price action, key news, forecasts, and analyses as of 2 December 2025. 1. How BlackRock (BLK) Traded on 2 December
3 December 2025
·
Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce, Inc. (NYSE: CRM) heads into a pivotal earnings week with its share price hovering in the mid‑$230s and Wall Street laser‑focused on whether the company’s big bet on AI and “agentic” workflows can re‑ignite growth. As of the close on December 2, 2025, Salesforce stock traded around $234.71, up roughly 0.8% on the day, with after‑hours quotes inching closer to $235.69. StockAnalysis Below is a comprehensive look at the latest price action, fresh analyst forecasts, institutional moves, and AI‑driven strategy updates, based on coverage and filings published up to December 2, 2025. Salesforce (CRM) stock price today and recent
3 December 2025
·
Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

As of December 2, 2025, Block, Inc. — the fintech behind Square, Cash App and Afterpay — is trading sharply lower even after reporting record holiday-shopping volumes and reiterating an ambitious multi‑year growth plan. Here’s a detailed look at what is happening with Block stock today, what the latest news means, and how Wall Street’s Block stock forecast is shaping up. Block stock today: sharp sell‑off on heavy volume On Tuesday, December 2, 2025, Block (NYSE: XYZ) closed around $60.11, down about 6.6% on the day. The stock traded between $59.97 and $65.28, with volume of roughly 20.7 million shares,
3 December 2025
·
1 … 920 921 922 923 924 … 1,174

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop